Ipsen Positive On Palovarotene Despite Troubled Past

Filings For FOP In Early 2021

 
• By Kevin Grogan
  
folders
Filings nearly ready for Ipsen's ultra rare bone disease drug • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Scrip